We also found that tumors release a protein called Activin-A, which acts on blood vessels to cause the leakiness and, ultimately, loss of blood vessels in the muscle. When we used a gene therapy to ...

Only a third of patients with advanced cancer had molecular testing to help guide the use of targeted therapies, a review of ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

Pancreatic cancer is one of the most lethal cancers, with only about 12% of patients surviving five years after diagnosis. A ...

A new study from Cedars-Sinai Cancer has revealed that doctors often misjudge the stage of early pancreatic cancer, with ...

The reason: there have been barely any medical advances for pancreatic cancer, like those that have consistently improved survival rates for other tumor types over the past decades. These are the risk ...

In 2024, an estimated 60,000 people in the US will be diagnosed with pancreatic cancer, and about 50,000 will die from it. Over 90% of PDAC tumors carry a RAS cancer driver mutation, with ~85% having ...

The composition of the gut microbiome appears to be associated with treatment response in patients with pancreatic cancer, research suggests.

The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the ...